Showing results 2 to 2 of 2
< previous
Title | Author(s) | Issue Date | Views | |
---|---|---|---|---|
Rationale and design of the TEMPO (tolvaptan efficacy and safety in management of autosomal dominant polycystic kidney disease and its outcomes) 3-4 study Journal:American Journal of Kidney Diseases | 2011 |